Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Proton beam therapy may improve treatment of rare but aggressive tumor

22.11.2006
Focusing radiation in the affected area leads to better control of cranial-base tumor

Proton beam radiation therapy, a very precise type of radiation treatment, may be an effective treatment for advanced adenoid cystic carcinoma that has spread to the cranial base, according to a study from the Francis H. Burr Proton Therapy Center at Massachusetts General Hospital (MGH).

In the November issue of Archives of Otolaryngology – Head and Neck Surgery, the research team describes results from 11 years of using proton therapy to treat this tumor, which can be dangerous when it spreads into the complex structures at the base of the skull.

"We are very encouraged by our results, in which local tumor control of advanced adenoid cystic carcinoma of the cranial base compared very favorably with results reported from traditional radiation therapy," says Annie Chan, MD, MGH Radiation Oncology, who led the study.

Frequently originating in the salivary glands, adenoid cystic carcinoma is an indolent but aggressive tumor that is usually treated surgically if diagnosed at an early stage. However, when it originates in or spreads into the cranial base – a complex area involving the cranial nerves, the eyes and critical brain structures – it is impossible to remove the tumor safely. Traditional radiation therapy has had limited success in controlling the tumors' growth, largely because the sensitive adjacent structures sharply limit the ability to deliver a strong enough dose.

Proton therapy takes advantage of an inherent quality of the positively charged atomic particles. As they travel through tissues, protons release most of their energy in a concentrated burst near the end of their range, which allows the power of the proton beam to be focused extremely precisely and spares surrounding structures. The MGH has used proton therapy to treat a variety of benign and malignant conditions since 1961 and in 2001 opened the Burr Proton Therapy Center, at the time the second hospital-based center in the world. Currently, proton therapy is offered in 25 centers worldwide, five of which are in the U.S.

The current study reports on a group of patients with very locally advanced adenoid cystic carcinoma involving the cranial base who were treated with high-dose proton beam therapy during the years 1991 through 2002. The majority of the patients could not undergo surgery, as the tumors were very advanced and involved critical structures in the brain or the cranial base. Patients were treated with high-dose proton beam radiation therapy, with treatment plans individually designed to target their specific tumors.

With proton beam treatment, only 9 percent of patients had local recurrence of their tumors, while with traditional radiation tumors recur locally more than 70 percent of the time. With tumors controlled locally in most patients, cancer that did recur was in the form of distant metastasis. However, more than half the patients remained free of recurrence through the end of the study period, up to eight years after surgery. Although blindness is a common side effect of traditional radiation to this area, none of the patients developed blindness with the proton beam treatment.

While the results of this study – the first known report of the use of proton beam therapy to treat this tumor – are better than trials of other types of radiation treatment, the researchers note that conducting the kind of randomized trial required to confirm a treatment's superiority would be difficult for such a rare tumor. However, multi-institutional prospective studies could further study the use of proton beam therapy to treat this rare and aggressive malignancy.

"We are now investigating whether combining proton beam radiation therapy with chemotherapy could further improve the outcome for these patients," says Chan, an assistant professor of Radiation Oncology at Harvard Medical School. The study was supported by the National Institutes of Health.

Sue McGreevey | EurekAlert!
Further information:
http://www.mgh.harvard.edu/

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Osaka university researchers make the slipperiest surfaces adhesive

18.10.2017 | Materials Sciences

Space radiation won't stop NASA's human exploration

18.10.2017 | Physics and Astronomy

Los Alamos researchers and supercomputers help interpret the latest LIGO findings

18.10.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>